Good day and welcome to Adaptive Biotechnologies third quarter financial results. (Operator Instructions) As a reminder, this call may be recorded. I would like to turn the call over to Karina ...

MOUNTAIN VIEW, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced ...

Adaptive Biotechnologies Corp (ADPT) reports a 22% revenue increase, driven by MRD growth, while managing cost reductions and ...

AN orange zombie fungus that sprouts from the backs of caterpillars could be used to fight cancer, new research suggests. Scientists have found the fungus, called Cordyceps, works by stopping cell ...

Reported interim RLY-2608 data demonstrating 9.2-month median PFS in heavily pre-treated patients with PI3Kα-mutated, HR+/HER2- metastatic breast ...

Conjunctival breach and a late onset are common in cases of endophthalmitis associated with implantation of an anti-VEGF delivery device.

Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its ...

Disease progression in metastatic breast cancer is a challenge that no single entity can solve alone. Breakthroughs in ...

BioVaxys Technology Corp. has joined the Rapid Response Partnership Vehicle, a consortium that supports the US Biomedical Advanced Research and Development Authority in accelerating vaccine ...

Over $5 million has been contributed to the One SC Fund at Central Carolina Community Foundation to rebuild South Carolina ...